NCT07513376 · Interventional trial
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Overall registry status Recruiting
Phase 3
Conditions Non-small Cell Lung Cancer
Delaware Valley sites
- Perelman Center for Advanced Medicine ( Site 3205) · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory